Phathom Pharmaceuticals Resubmits Erosive GERD New Drug Application to FDA

Go back to Phathom Pharmaceuticals Resubmits Erosive GERD New Drug Application to FDA
(NASDAQ: PHAT) Delayed: 8.62 -0.7 (7.51%)
Previous Close $9.32    52 Week High
Open $9.25    52 Week Low
Day High $9.30    P/E N/A 
Day Low $8.61    EPS
Volume 372,294